Oncoclinicas audit committee says Q2 financials are adequate, flags going-concern uncertainty

• Oncoclinicas’ audit, risk and compliance committee met Aug. 11, 2026 to review interim financial statements for the quarter ended June 30, 2026.
• Committee concluded the standalone and consolidated interim accounts were adequate under CVM rules and applicable accounting standards.
• Review included the draft independent auditor’s report, with an emphasis paragraph flagging material uncertainty over going concern.
• Members noted management remediation steps, citing court approval of an out-of-court restructuring request as key to the going-concern assumption.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncoclinicas do Brasil Servicos Medicos SA published the original content used to generate this news brief on August 14, 2026, and is solely responsible for the information contained therein.